Aprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) Associated With Highly Emetogenic Chemotherapy (0869-801)(COMPLETED)
Clinical trial NCT00090207 · COMPLETED
Trial details
- NCT number
- NCT00090207
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2004-01-13
- Primary completion
- 2004-09-30
- Enrollment
- 477
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.